Anshu Giri, MD, MS

Request an Appointment

Call 888-369-2427

Request Online

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427

Chief, General Hematology/Oncology

Associate Professor, Department of Hematology/Oncology

Oncology Informatics Physician Lead

Specialties

  • Breast Medical Oncology ; 
  • Head and Neck Medical Oncology

Areas of Expertise

Head & Neck Cancer, Breast Cancer, Brain & Spinal Tumors, Thyroid Cancer

Distinctions

Treatment Philosophy

For a cancer patient the ideal treatment maximizes quality of life, while minimizing side effects. My philosophy as an oncologist is to guide the patient toward achieving this goal. I strive to ensure that patients and their families have a comprehensive understanding of their disease and available treatment options. In addition, I believe a patient deserves to be treated functionally, emotionally, and socially, as a whole person. By being a part of Fox Chase Cancer Center, I will be working with a team devoted to making this happen.

After completing my fellowship at the Medical University of South Carolina, I am excited to join Fox Chase and the vibrant medical community in Philadelphia. I was immediately impressed by the collegiality of the faculty and staff, as well as the multidisciplinary approach to their care. I am enthusiastic about being involved in the treatment of a variety of solid tumors.
 

Educational Background

  • Hematology Oncology Fellowship, Medical University of South Carolina, Charleston, SC, 2016-2019
  • Internal Medicine Residency, Upstate Medical University, Syracuse, NY, 2013-2016
  • MD, St. George’s University, Grenada, 2009-2013
  • MS, Medical Sciences, Wayne State University, Detroit, MI, 2006-2008
  • BS, Chemistry, University of Michigan, Ann Arbor, MI, 2003-2006

Certifications

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Hematology
  • American Board of Internal Medicine - Medical Oncology

Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology

Honors & Awards

  • Philadelphia Magazine's Top Doctors: 2023-2026

Lisa Shustack

  • Breast Cancer

A few years ago, when I was 46, something unusual showed up on my yearly mammogram. So they did an ultrasound and said I should come back every six months for monitoring for the next two years.

For 18 months, there was no change. Then, in April of 2023, I went for my last follow-up scan. When we finished, instead of sending me home, the radiologist came into the room to talk to me. I knew then that something wasn’t right.

She said there had been a change since my last scan. It looked like I had a malignancy in my right breast, and we would need a biopsy to be sure.

VIEW PATIENT STORY

Selected Publications

Giri, A., Walia, SS., Gajra, A. Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer. Rev Recent Clin Trials. 2016, Jul 24.

Pinto, I., Giri, A., Arshad, U., Gajra, A. New Oral Anticoagulants and Their Reversal. Current Drug Safety. 2015; 10 (3): 208-16.

Aleksiejuk, P., Pawar, L., Giri, A.. Conservative Management of Spontaneous Esophageal Perforation in a Patient with Achalasia. Critical Care Medicine. 2014, Dec; 42(12): A1660.

Giri, A., Goustin, A.S., Wang, S., Al-Katib, A., Mohammad, R.. Surface plasmon resonance study of apoptotic regulators Bcl-2, Bcl-w, Bcl-XL, Mcl-1 and A1 and the small molecule inhibitor (SMI) TW-37: the idea of a temporal window for drug activity. Cancer Research. 2008, May; 68(9S): 3192.

Mohammad, R., Giri, A., Goustin, A. S.. Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer. Recent patents on anti-cancer drug discovery. 2008, Jan; 3(1): 20-30.

Related Articles